Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Alliance Entertainment Promotes Seven Executives to Senior Vice President Roles
-
NordVPN launches Scam Call Protection feature for Android users in the US
-
Kandi Technologies’ AI and Robotics Solutions Featured at WAIC 2025
-
DeFi Dev Corp. Establishes Strategic Partnership with Solflare, Becomes Official Wallet Provider
-
Stran & Company to Announce Second Quarter 2025 Financial Results and Business Update Conference Call
-
Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidati
-
IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results
-
SecureTech Announces Uplisting to OTCQB Venture Market
-
Empro Group Inc. Announces Closing of Remaining Portion of the Underwriter’s Over-Allotment Option in Connection with its Upsized Initial Public Offering
-
Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives
-
Nightfood Holdings Advances $80 Million in Strategic Hotel Acquisitions to Anchor AI-Powered Hospitality Platform
-
Ocugen Provides Business Update with Second Quarter 2025 Financial Results
-
SUTNTIB AB Tewox publishes its NAV for July 2025
-
EHang Partners with Wanyi Tianxia to Complete Groundbreaking Long-Range UAV Cargo Flights in the Greater Bay Area with Intercity Round-Trip Between Zhuhai and Guangzhou
-
OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case
-
Bridger Aerospace Announces Schedule for its Second Quarter 2025 Earnings Release and Conference Call
-
Axis Wake Launches the 2026 T250, the Largest and Most Powerful Axis Ever Built
-
I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares
-
Abercrombie & Fitch Co. to Report Second Quarter 2025 Results on August 27, 2025
-
Ascentage Pharma to Participate in Evercore China Biotech Summit
-
Aemetis to Review Second Quarter 2025 Financial Results on August 7, 2025
-
Oxford Square Capital Corp. Prices Public Offering of $65 Million 7.75% Notes Due 2030
-
NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement
-
ETH Contract Participation Model for 2025 Announced by HashJ to Tap Market Opportunities
-
Cemtrex Issues Shareholder Update Highlighting Growth Across Vicon and AIS Divisions, Strategic Initiatives in Blockchain and Automation
-
Greif to Close Steel and Polymer Facility in Merced, California
-
Legend Senior Living Expands Management Team, Naming Brian Donnelly as Director of Dining Experience
-
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Travel eSIM app Saily debuts Ultra, a new premium plan for unparalleled journeys
-
Abercrombie & Fitch Co. to Report Second Quarter 2025 Results on August 27, 2025
-
NordStellar achieves SOC 2 Type II compliance, demonstrating its commitment to security
-
Viasat Comments on Letter from Carronade Capital Management
-
Orchestra BioMed Announces Pricing of $40 Million Public Offering
-
Lánasjóður sveitarfélaga - Útboð LSS 39 0303 og LSS151155
-
Bitget Surges to 7.2% Global Derivatives Market Share, Ranks Top 3 Highlights Bitcoin.com Report
-
FOXO TECHNOLOGIES INC.’S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES
-
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.08 per Share for August 2025
-
Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); Flywire Corporation (NASDAQ: FLYW); Replimune Group, Inc. (NASDAQ: REPL); and Sable Offshore Corporation (NYSE: SOC): Gra
-
Form 8.3 - [NCC GROUP PLC - 31 07 2025] - (CGAML)
-
IES Holdings Reports Fiscal 2025 Third Quarter Results
-
Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company’s Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of Anxiety and Depression
-
Internationally Certified MICE Training Programme Launched in the GBA, Strengthening Talent Integration Between Macao and Hengqin
-
Notice of Knight Therapeutics' Second Quarter 2025 Results Conference Call
-
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Aptose Selects Ernst & Young Global Limited as its New Independent Auditor and Calls Reconvened Meeting of its Shareholders
-
NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Nexxen Announces July 2025 Share Repurchase Program Summary
-
HTX Hot Listings Weekly Recap (July 21 - 28): SOL Memes & ETH DeFi Drive Market Surge, New Assets on HTX Post Impressive Gains
-
HTX Hot Listings Weekly Recap (July 21 - 28): SOL Memes & ETH DeFi Drive Market Surge, New Assets on HTX Post Impressive Gains
